Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH2 | P25021 | 4/20 | 0.61 |
| ▸ | HRH1 | P35367 | 4/20 | 0.61 |
| ▸ | HRH3 | Q9Y5N1 | 9/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6847378 | 0.86 | HRH2 (0.46) | HRH2HRH1HRH3 | |
| SCHEMBL6846632 | 0.82 | HRH2 (0.60) | HRH2HRH1HRH3TSHRLMNA | |
| SCHEMBL6842225 | 0.82 | HRH2 (0.59) | HRH2HRH1HRH3GAA | |
| SCHEMBL6846813 | 0.80 | HRH2 (0.48) | HRH2HRH1HRH3GAA | |
| SCHEMBL5220974 | 0.75 | P2RX7 (0.49) | HRH2HRH1HRH3 | |
| SCHEMBL5215408 | 0.74 | HRH2 (0.69) | HRH2HRH1HRH3 | |
| SCHEMBL6848230 | 0.74 | HRH2 (0.46) | HRH2HRH1HRH3GAA | |
| SCHEMBL6986426 | 0.74 | HRH2 (0.49) | HRH2HRH1HRH3GAACHRM4 | |
| SCHEMBL6847414 | 0.74 | KMT2A (0.43) | HRH2HRH1HRH3 | |
| SCHEMBL29173061 | 0.72 | HDAC1 (0.49) | TSHRLMNAGAAMAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1467727-A1 | 1,3-DISUBSTITUTED AND 1,3,3,-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | Abbott Laboratories (US) | 2004-10-20 | — | — | EP | disclosed |
| WO-2003059341-A1 | 1,3-DISUBSTITUTED AND 1,3,3,-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | ABBOTT LABORATORIES (US) | 2003-07-24 | — | — | WO | disclosed |